SMT201400064B - Procedimento per la produzione di acido 2-[(3,5-difluoro-3'-metossi-1,1'-bifenil-4-il) amino] nicotinico - Google Patents

Procedimento per la produzione di acido 2-[(3,5-difluoro-3'-metossi-1,1'-bifenil-4-il) amino] nicotinico

Info

Publication number
SMT201400064B
SMT201400064B SM201400064T SM201400064T SMT201400064B SM T201400064 B SMT201400064 B SM T201400064B SM 201400064 T SM201400064 T SM 201400064T SM 201400064 T SM201400064 T SM 201400064T SM T201400064 B SMT201400064 B SM T201400064B
Authority
SM
San Marino
Prior art keywords
difluoro
biphenyl
methoxy
amino
production
Prior art date
Application number
SM201400064T
Other languages
English (en)
Italian (it)
Inventor
Bernardini Maria Carmen Boix
Original Assignee
Almirall Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Almirall Sa filed Critical Almirall Sa
Publication of SMT201400064B publication Critical patent/SMT201400064B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/78Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
    • C07C217/80Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton having amino groups and etherified hydroxy groups bound to carbon atoms of non-condensed six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/803Processes of preparation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
SM201400064T 2009-10-16 2014-06-03 Procedimento per la produzione di acido 2-[(3,5-difluoro-3'-metossi-1,1'-bifenil-4-il) amino] nicotinico SMT201400064B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09382212A EP2314577A1 (fr) 2009-10-16 2009-10-16 Procédé de fabrication de l'acide 2-[(3,5-difluoro-3'-méthoxy-1,1'-biphényl-4-yl)amino]nicotinique
PCT/EP2010/006283 WO2011045059A1 (fr) 2009-10-16 2010-10-14 Procédé de fabrication d'acide 2-[(3,5-difluoro-3'-méthoxy-1,1'-biphényl-4-yl)amino]nicotinique

Publications (1)

Publication Number Publication Date
SMT201400064B true SMT201400064B (it) 2014-07-07

Family

ID=41402565

Family Applications (1)

Application Number Title Priority Date Filing Date
SM201400064T SMT201400064B (it) 2009-10-16 2014-06-03 Procedimento per la produzione di acido 2-[(3,5-difluoro-3'-metossi-1,1'-bifenil-4-il) amino] nicotinico

Country Status (32)

Country Link
US (1) US8598363B2 (fr)
EP (2) EP2314577A1 (fr)
JP (1) JP5809630B2 (fr)
KR (1) KR101699999B1 (fr)
CN (2) CN103936668A (fr)
AU (1) AU2010306098B2 (fr)
BR (1) BR112012008464B1 (fr)
CA (1) CA2776328C (fr)
CL (1) CL2012000739A1 (fr)
CO (1) CO6430508A2 (fr)
CR (1) CR20120185A (fr)
CY (1) CY1115161T1 (fr)
DK (1) DK2488497T3 (fr)
EA (1) EA022805B1 (fr)
ES (1) ES2467165T3 (fr)
HR (1) HRP20140523T1 (fr)
IL (1) IL218446A (fr)
IN (1) IN2012DN01938A (fr)
ME (1) ME01812B (fr)
MX (1) MX2012004033A (fr)
MY (1) MY160308A (fr)
NZ (1) NZ598429A (fr)
PE (1) PE20121173A1 (fr)
PH (1) PH12012500548A1 (fr)
PL (1) PL2488497T3 (fr)
PT (1) PT2488497E (fr)
RS (1) RS53319B (fr)
SI (1) SI2488497T1 (fr)
SM (1) SMT201400064B (fr)
UA (1) UA107811C2 (fr)
WO (1) WO2011045059A1 (fr)
ZA (1) ZA201201563B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2319596B1 (es) 2006-12-22 2010-02-08 Laboratorios Almirall S.A. Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico.
UY31272A1 (es) * 2007-08-10 2009-01-30 Almirall Lab Nuevos derivados de ácido azabifenilaminobenzoico
EP2135610A1 (fr) * 2008-06-20 2009-12-23 Laboratorios Almirall, S.A. Combinaison comportant des inhibiteurs DHODH et de la méthotrexate
EP2239256A1 (fr) 2009-03-13 2010-10-13 Almirall, S.A. Sel de sodium de l'acide 5-cyclopropyl-2-{[2-(2,6-difluorophényl)pyrimidin-5-yl]amino}benzoïque en tant qu'inhibiteurs de la DHOD
JP7343373B2 (ja) * 2019-12-02 2023-09-12 花王株式会社 香料組成物

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT837710E (pt) 1995-06-21 2002-05-31 Sofotec Gmbh & Co Kg Cartucho de po farmaceutico com dispositivo de doseamento integrado e inalador para medicamentos em po
DE19547648A1 (de) 1995-12-20 1997-06-26 Hoechst Ag Zubereitung, enthaltend High Density Lipoproteine und Crotonsäureamidderivate
DE19610955A1 (de) 1996-03-20 1997-09-25 Hoechst Ag Kombinationspräparat, enthaltend 5-Methylisoxazol-4-carbonsäure-(4-trifluormethyl)- anilid und N-(4-Trifluormethylphenyl)-2-cyan-3- hydroxycrotonsäureamid
GB9804343D0 (en) 1998-02-27 1998-04-22 Univ Cardiff Chemical compounds
PL352430A1 (en) 1999-06-10 2003-08-25 Warner Lambert Co Method of inhibiting agreggation of amyloid proteins and visualising amyloid deposits
EP1381356B1 (fr) 2001-04-05 2008-05-28 Aventis Pharmaceuticals Inc. Utilisation de l'acide (z)-2-cyano-3-hydroxy-but-2-enoique-(4'-trifluoromethylphenyl)-amide pour le traitement de la sclerose en plaques
PE20030120A1 (es) 2001-06-19 2003-02-12 Merck & Co Inc Sal amina de un antagonista de receptor de integrin
DE10129703A1 (de) 2001-06-22 2003-01-02 Sofotec Gmbh & Co Kg Zerstäubungssystem für eine Pulvermischung und Verfahren für Trockenpulverinhalatoren
MXPA04000224A (es) 2001-07-10 2005-07-25 4Sc Ag Novedosos compuestos como agentes antiinflamatorios, inmunomoduladores y antiproliferativos.
US7258118B2 (en) 2002-01-24 2007-08-21 Sofotec Gmbh & Co, Kg Pharmaceutical powder cartridge, and inhaler equipped with same
DE10202940A1 (de) 2002-01-24 2003-07-31 Sofotec Gmbh & Co Kg Patrone für einen Pulverinhalator
KR20040081201A (ko) * 2002-02-13 2004-09-20 글락소 그룹 리미티드 항정신병제로서 벤젠술폰아미드 유도체
US20070135488A1 (en) * 2002-04-13 2007-06-14 Chung You S Amlodipine nicotinate and process for the preparation thereof
PE20040844A1 (es) * 2002-11-26 2004-12-30 Novartis Ag Acidos fenilaceticos y derivados como inhibidores de la cox-2
EP1581478A1 (fr) 2002-12-23 2005-10-05 4Sc Ag Inhibiteurs de l'enzyme dhodh et leur procede d'identification
US7071355B2 (en) 2002-12-23 2006-07-04 4 Sc Ag Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents
SE0400234D0 (sv) 2004-02-06 2004-02-06 Active Biotech Ab New compounds, methods for their preparation and use thereof
EP1763346A4 (fr) 2004-05-21 2009-03-04 Uab Research Foundation Composition et methodes se rapportant aux inhibiteurs de la synthese de la pyrimidine
WO2006022442A1 (fr) 2004-08-24 2006-03-02 Santen Pharmaceutical Co., Ltd. Nouveaux derives d’amides heterocycliques ayant une activite d’inhibition de la dihydroorotate deshydrogenase
CA2584655A1 (fr) 2004-10-19 2006-04-27 Aventis Pharmaceuticals Inc. Emploi du (4'-trifluoromethylphenyl)amide de l'acide (z)-2-cyano-3-hydroxy-but-2-enoique dans le traitement d'affections abdominales inflammatoires
ES2265276B1 (es) 2005-05-20 2008-02-01 Laboratorios Almirall S.A. Derivados de 4-(2-amino-1-hidroxietil)fenol como agonistas del receptor beta2 adrenergico.
CN1696100B (zh) * 2005-06-01 2010-11-24 黑龙江福和华星制药集团股份有限公司 痤疮治疗药阿达帕林的新型简捷合成方法
ES2319596B1 (es) 2006-12-22 2010-02-08 Laboratorios Almirall S.A. Nuevos derivados de los acidos amino-nicotinico y amino-isonicotinico.
JP5349332B2 (ja) 2007-02-06 2013-11-20 チェルシー・セラピューティクス,インコーポレイテッド 新規化合物、その調製方法、およびその使用
UY31272A1 (es) 2007-08-10 2009-01-30 Almirall Lab Nuevos derivados de ácido azabifenilaminobenzoico
EP2135610A1 (fr) 2008-06-20 2009-12-23 Laboratorios Almirall, S.A. Combinaison comportant des inhibiteurs DHODH et de la méthotrexate
EP2210615A1 (fr) 2009-01-21 2010-07-28 Almirall, S.A. Combinaisons comportant des inhibiteurs DHODH et de la méthotrexate
EP2239256A1 (fr) 2009-03-13 2010-10-13 Almirall, S.A. Sel de sodium de l'acide 5-cyclopropyl-2-{[2-(2,6-difluorophényl)pyrimidin-5-yl]amino}benzoïque en tant qu'inhibiteurs de la DHOD
EP2230232A1 (fr) 2009-03-13 2010-09-22 Almirall, S.A. Sels adjuvants de trométhamine dotés de dérivés d'acide azabiphénylaminobenzoïque en tant qu'inhibiteurs de la DHOD
EP2228367A1 (fr) 2009-03-13 2010-09-15 Almirall, S.A. Sels adjuvants d'amines contenant des groupes hydroxyle et/ou carbonyle avec des dérivés d'acides aminonicotiques en tant qu'inhibiteurs de la DHODH

Also Published As

Publication number Publication date
IN2012DN01938A (fr) 2015-08-21
CO6430508A2 (es) 2012-04-30
EA201200594A1 (ru) 2012-11-30
EP2314577A1 (fr) 2011-04-27
PT2488497E (pt) 2014-05-28
EP2488497A1 (fr) 2012-08-22
DK2488497T3 (da) 2014-06-10
HK1168101A1 (en) 2012-12-21
PE20121173A1 (es) 2012-08-30
CN102574800B (zh) 2014-09-17
CA2776328C (fr) 2017-08-08
PH12012500548A1 (en) 2012-11-12
CR20120185A (es) 2012-06-11
IL218446A0 (en) 2012-04-30
CY1115161T1 (el) 2016-12-14
KR20120087131A (ko) 2012-08-06
EA022805B1 (ru) 2016-03-31
CN102574800A (zh) 2012-07-11
EP2488497B1 (fr) 2014-03-12
CN103936668A (zh) 2014-07-23
ME01812B (me) 2014-09-20
JP5809630B2 (ja) 2015-11-11
MX2012004033A (es) 2012-05-08
US20120245359A1 (en) 2012-09-27
NZ598429A (en) 2014-02-28
SI2488497T1 (sl) 2014-08-29
JP2013507407A (ja) 2013-03-04
CA2776328A1 (fr) 2011-04-21
CL2012000739A1 (es) 2012-10-12
KR101699999B1 (ko) 2017-01-26
BR112012008464A2 (pt) 2015-09-22
IL218446A (en) 2014-08-31
HRP20140523T1 (hr) 2014-07-04
ZA201201563B (en) 2012-11-28
WO2011045059A1 (fr) 2011-04-21
RS53319B (sr) 2014-10-31
US8598363B2 (en) 2013-12-03
AU2010306098A1 (en) 2012-03-15
AU2010306098B2 (en) 2015-10-15
UA107811C2 (en) 2015-02-25
PL2488497T3 (pl) 2014-07-31
BR112012008464B1 (pt) 2021-08-24
ES2467165T3 (es) 2014-06-12
MY160308A (en) 2017-02-28

Similar Documents

Publication Publication Date Title
IT1401911B1 (it) Processo per la sintesi di acido 2,5-furandicarbossilico
EP2650277A4 (fr) Procédé de production d'acide 2-bromo-4,5-dialkoxybenzoïque
EP2552873A4 (fr) Procédé pour la fabrication d'hexafluoro-2-butène
ZA201100631B (en) "production method of isoxazoline-substituted benzoic acid amide compound"
BRPI0905928A2 (pt) "método de produção de ácido lático"
IT1392214B1 (it) Processo per la produzione di un composto dell'acido n-butirrico in forma microincapsulata, destinato ad alimentazione animale od umana
BRPI1015062A2 (pt) "processo para preparar ácido fórmico"
PL2297079T3 (pl) Proces wytwarzania kwasu glikolowego
BRPI1014326A2 (pt) metodo continuo para producao de amidas de acidos carboxilicos alifaticos
EP2650376A4 (fr) Procédé de production d'acide l-aminé
EP2703343A4 (fr) Procédé pour la production d'oxyde/d'hydroxyde
SMT201400064B (it) Procedimento per la produzione di acido 2-[(3,5-difluoro-3'-metossi-1,1'-bifenil-4-il) amino] nicotinico
FR2947265B1 (fr) Procede de preparation d'alkylalcanolamines
HUE040484T2 (hu) Eljárás (3S,3S')4,4'-diszulfándiilbisz(3-aminobután-1-szulfonsav) elõállítására
BR112012025490A2 (pt) ''método para produção de 1,5 oebtanodiamina''
BR112012017828A2 (pt) ''método para a produção de um produto químico por fermentação contínua''
IL207431A0 (en) New process for the preparation of cyclohexanecarboxylic acid derivatives
BRPI1012007A2 (pt) "método para a preparação de ácido 2-ceto-carboxílico"
EP2421875A4 (fr) Procédé hautement sélectif pour la production d'organodiphosphites
IT1396172B1 (it) Procedimento integrato per la produzione di idrogeno da acido solfidrico
IT1393095B1 (it) Processo per la sintesi del sale disodico dell'acido ursodesossicolico 3,7-disolfato.
FR2974804B1 (fr) Procede de preparation d'un acide glycolique de haute purete
EP2571836A4 (fr) Procédé de fabrication d'hexafluoro-2-butyne
IT1394296B1 (it) Metodo di sintesi dell'acido glicocolico.
EP2397545A4 (fr) Procédé de production d'un acide aminé